Christopher Garabedian
2013
In 2013, Christopher Garabedian earned a total compensation of $9.7M as Former President and Chief Executive Officer at Sarepta Therapeutics, a 267% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $362,500 |
|---|---|
| Option Awards | $8,576,970 |
| Salary | $580,000 |
| Other | $182,022 |
| Total | $9,701,492 |
Garabedian received $8.6M in option awards, accounting for 88% of the total pay in 2013.
Garabedian also received $362.5K in non-equity incentive plan, $580K in salary and $182K in other compensation.
Rankings
In 2013, Christopher Garabedian's compensation ranked 430th out of 12,286 executives tracked by ExecPay. In other words, Garabedian earned more than 96.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 430 out of 12,286 | 97th |
Division Manufacturing | 132 out of 4,612 | 97th |
Major group Chemicals And Allied Products | 34 out of 1,462 | 98th |
Industry group Drugs | 21 out of 1,156 | 98th |
Industry Pharmaceutical Preparations | 19 out of 890 | 98th |
Source: SEC filing on May 31, 2016.
Garabedian's colleagues
We found four more compensation records of executives who worked with Christopher Garabedian at Sarepta Therapeutics in 2013.